Web seminar, hosted by the National Heart, Lung, and Blood Institute (NHLBI) PACT Program
September 3, 2020
12:00 pm – 1:00 pm
Methods for Cellular Therapies: Tracking Cells In Vivo and Assessing Biodistribution in Patients
What are your cells doing? Where do they go?
The HESI Cell Therapy - TRAcking, Circulation, & Safety (CT-TRACS) Committee is pleased to present a webinar on "Methods for Cellular Therapies: Tracking Cells In Vivo and Assessing Biodistribution in Patients" in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) PACT Program.
- Date: Thursday, 3 September 2020
- Time: 12:00 PM - 1:00 PM EST
- Registration: Click here to register.
- Bill Shingleton, PhD, Alliances Manager at Cytiva
- Brooke Helfer, PhD, Director of Research and Development at Celsense, Inc.
- David Morrow, PhD, MBA, ATMP and Vaccine Scientific Program Manager at EATRIS
Cell therapies show great therapeutic promise in the fields of regenerative medicine and immunotherapy. To realize their full clinical potential, there is a need for greater understanding of their mode of action, how they migrate after administration to deliver their therapeutic benefits, their persistence at sites of action, and whether their properties, localization, or distribution may cause safety issues. Currently, there are several existing and many emerging tools available to develop pharmacokinetic data on these cell-derived therapies to improve our understanding of the mechanism of action and demonstrate on-target delivery, but adoption by clinical investigators has been limited.
In this web seminar, the CT-TRACS Committee speakers will provide an overview of technologies currently available for use in patients, how these are relevant to evaluate safety and efficacy aspects of cellular therapies, and the importance of collaboration to address challenges and needs facing the translation of cell therapies into the clinic.
The CT-TRACS Committee provides a neutral platform for cell therapy developers, researchers, regulators, imaging specialists, and other stakeholders to interact, discuss current challenges, and identify best practices to improve confidence in the safety and efficacy of these therapies.
- To learn about available and emerging noninvasive cell tracking modalities and their value in assessing cell fate and safety in vivo
- To bring awareness on how the application of existing cell tracking technologies, methods, and best practices can benefit the clinical translation of cell therapies
- To emphasize the need for dialogue with the international community and discuss opportunities to address the challenges facing the translation of cell therapies into the clinic
- To understand the importance of therapy developers communicating practical challenges and needs to aid the development of enabling technologies and tools addressing those needs
Additional details can be found via the webinar e-flyer here. For more information, please contact the CT-TRACS Committee's Senior Scientific Program Manager, Dr. Lucilia Mouriès at email@example.com.